AquaBounty Technologies Inc logo

ABTU - AquaBounty Technologies Inc Share Price

662.5p 0.0  0.0%

Last Trade - 30/05/17

Sector
Healthcare
Size
Micro Cap
Market Cap £27.8m
Enterprise Value £26.6m
Revenue £112k
Position in Universe th / 1830
Bullish
Bearish
Unlock ABTU Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ABTU Revenue Unlock ABTU Revenue

Net Income

ABTU Net Income Unlock ABTU Revenue

Normalised EPS

ABTU Normalised EPS Unlock ABTU Revenue

PE Ratio Range

ABTU PE Ratio Range Unlock ABTU Revenue

Dividend Yield Range

ABTU Dividend Yield Range Unlock ABTU Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ABTU EPS Forecasts Unlock ABTU Revenue
Profile Summary

AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company's AquAdvantage Salmon.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated December 17, 1991
Public Since September 17, 2002
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange London Stock Exchange
Shares in Issue 21,605,322
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABTU Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to ABTU
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.